Somatic stem cells
US8679474B2 · kind B2 · utility
0Cited by
1References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 6, 2012 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | Feb 6, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a cellular proliferative disorder with cancer antigen-activated dendritic cells that are derived from a population of somatic stem cells. Also disclosed are methods of treating tissue damages and degenerative diseases with a population of somatic stem cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.